Harvest Portfolios Group Inc. Has $74.13 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Harvest Portfolios Group Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 126,790 shares of the healthcare conglomerate’s stock after selling 12,862 shares during the quarter. UnitedHealth Group comprises about 2.5% of Harvest Portfolios Group Inc.’s investment portfolio, making the stock its 5th biggest position. Harvest Portfolios Group Inc.’s holdings in UnitedHealth Group were worth $74,132,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group in the third quarter worth $27,000. Global Wealth Strategies & Associates grew its holdings in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Macroview Investment Management LLC raised its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 3rd quarter valued at $32,000. Finally, Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on UNH. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Robert W. Baird boosted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Finally, Morgan Stanley cut their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Performance

UNH opened at $605.00 on Wednesday. The business’s fifty day moving average is $580.96 and its 200-day moving average is $543.36. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The firm has a market cap of $558.67 billion, a P/E ratio of 36.94, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the company posted $6.56 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.39%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.